1.School of Pharmacy, Harbin Medical University, Harbin 150086, China; 2. Department of Pharmacy, The Second Affiliated Hospital, Harbin Medical University, Harbin 150086, China
In recent years, with the in-depth research on mitochondria, people realize that mitochondria have a vital role for apoptosis of cancer cells. This finding promotes the development of mitochondrial targeting agents. Anticancer drugs modified with mitochondrial targeting molecules specifically acts on mitochondria and induce apoptosis of tumor cells to achieve targeting anti-tumor effect, so that the efficacy is improved while systemic toxicity of anticancer drugs is reduced. Mitochondrial targeting molecules have broad potential applications in anticancer drugs. This paper reviews the latest research progress of mitochondrial targeting molecules for cancer therapy, providing a reference for the treatment of cancer from the mitochondrial pathway
[1] SONG H, CHEN N, XU C R. The advances research of mitochondrial-targeting antitumor drugs . Heilongjiang Med J(黑龙江医药), 2013, 26(2):290-292. [2] ZHOU Y Y, GUO Q H, GU X X. The dynamic introduction of anti-cancer drug research . Chin J Chem Ed(化学教育), 2004, 25(5):10-13. [3] SHTIL A A, MANDLEKER S, YU R, et al. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells . Oncogene, 1999, 18(2):377-384. [4] JIANG L Z, LI T L, HONG Y. Advances in research on targeting mitochondria for cancer therapy . Anhui Med Pharm J(安徽医药), 2011, 15(11):1329-1332. [5] GOGVADZE V, ORRENIUS S, ZHIVOTOVSHY B. Mitochondria in cancer cells:What is so special about them . Trends Cell Biol, 2008, 18(4):73-165. [6] ZHU Y S, CHEN J. Mitochondria and cell apoptosis regulation . Life Sci J(生命科学), 2008, 20(4):506-513. [7] SUN X Y, WEI L L, CHEN H L, et al. The advances research of nano-carrier inorganelle-targeting . Acta Pharm Sin(药学学报),2009,44(8):838-844. [8] ROZENZHAK S M, KADAKIA M P, CASERTA T M, et al. Cellular internalization and targeting of semiconductor quantum dots . Chem Commun(Camb), 2005, 7(17):2217-2219. [9] SZETO H H. Mitochondria-targeted cytoprotective peptides for ischemia reperfusion injury . Antioxid Redox Signal, 2008, 10(3):601-619. LEI K L, PAN L L. New mitochondrial-targeting antitumor drugs . J Tongren Univ(铜仁学院学报), 2012, 14(6):135-137. CALLAHAN J, KOPECEK J. Semitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization . Biomacromolecules, 2006, 7(8):2347-2356. LIU R, YE L. Beta amyloid peptide in alzheimer's disease and mitochondrial dysfunction and targeting therapy . J Int Neurol Neurosurg(国际神经病学神经外科学杂志), 2010, 37(3):270-275. GOGVADZE V, ORRENIUS S, ZHIVOTOVSHY B. Mitochondria as targets for chemotherapy . Apoptosis, 2009, 14(4):624-640. TAUSKELA J S. MitoQ-a mitochondria-targeted antioxidant . IDrugs, 2007, 10(6):399-412. CASSINA P, CASSINA A, PEHARM M, et al. Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration:Prevention by mitochondrial-targeted antioxidants . J Neurosci, 2008, 28 (16):4115-4122. DONG L F, VICTORIA J A, DAVID T Y, et al.Mitochondrial targeting of α-tocopheryl succinate enhances its pro-apoptotic efficacy:A new paradigm for effective cancer therapy . Free Radical Biol Med, 2011, 50(11):1546-1555. JAROMIRA K, MARTINA B, MAGDALENA V, et al. Mitochondrial targeting of α-tocopheryl succinate enhances its anti-mesothelioma efficacy . Redox Report, 2014, 19(1):16-20. ZHOU J, ZHAO W Y, MA X, et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial-targeting conjugate in resistant lung cancer . Biomaterials, 2013, 34(14):3626-3638. CHERUKU A R, VENKATESWARLU S, TRIMURTULU G, et al. Mitochondrial-Targeted curcuminoids:A strategy to enhance bioavailability and anticancer efficacy of curcumin. PLoS One, 2014,9(3),e89351:1-11. D′SOUZA G G, RAMMOHAN R, CHENG S M, et al. DQA some-mediated delivery of plasmid DNA toward mitochondria in living cells . J Controlled Release, 2003, 92(1-2):189-197. MA X, ZHOU J, ZHANG C X, et al. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes . Biomaterials, 2013, 34(18):4452-4465. YU S C, QIAN G S, HUANG G J. F16, A new kind of mitiochondrial targeting anti-cancer molecular . Chem Life(生命的化学), 2004, 24(5):421-423. SIANG H L, WU L X, LIK V K, et al. Rosamines Targeting the cancer oxidative phosphorylation pathway . PLoS One, 2014, 9(3),e82934:1-10. LETASIOVA S, JANTOVA S, MIKO M, et al. Effect of berberine on proliferation, biosynthesis of macromolecules, cell cycle and induction of intercalation with DNA, dsDNA damage and apoptosis in Ehrlich ascites carcinoma cells. J Pharm Pharmacol, 2006, 58(2):263-270. MANTENA S K, SHARMA S D, KATIYAR S K, et al. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells . Mol Cancer Therapeu, 2006, 5(2):296-308. LIN C C, KAO S T, CHEN G W, et al. Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3 . Anticancer Res, 2006, 26(1A):227-242. KONSTANTIN G, LYAMZAEV A V, PUSTOVIDKO R, et al. A novel mitochondria-targeted antioxidants:Plastoquinone conjugated with cationic plant alkaloids berberine and palmatine . Pharm Res, 2011, 28(11):2883-2895. PIA A E, PLAMENA R A, MICHAL K, et al. Polyhydroxybutyrate targets mammalian mitochondria and increases permeability of plasmalemmal and mitochondrial membranes . PLoS One, 2013, 8(9):2-10. CHIARA R,BARBARA R, JOANNA K, et al. Mitochondrial-Targeting nitrooxy-doxorubicin:A new approach to overcome drug resistance . Mol Pharm, 2013, 10(1):161-174.